Global Breakthrough Therapy (BT) Designation Market Size, Status and Forecast 2020-2026
This report focuses on the global Breakthrough Therapy (BT) Designation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breakthrough Therapy (BT) Designation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Roche
- Abbvie
- Novartis International AG
- Janssen
- BMS
- Eli Lilly
- Gilead
- Sanofi
- Regeneron
- Acadia
- Boehringer Ingelheim
- Amgen
- AstraZeneca
- GlaxoSmithKline
- Vertex
- Alexion
- Merck
- Jazz Pharmaceuticals
- Exelixis
- Eisai
- Takeda
- Pfizer
- Oncology
- Infectious Diseases
- Rare Diseases
- Autoimmune Diseases
- Pulmonary Diseases
- Neurological Disorders
- Others
- Hospital
- Clinic
- Research Institute
- Laboratories
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Breakthrough Therapy (BT) Designation status, future forecast, growth opportunity, key market and key players.
- To present the Breakthrough Therapy (BT) Designation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breakthrough Therapy (BT) Designation Revenue
1.4 Market Analysis by Type
1.4.1 Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 Infectious Diseases
1.4.4 Rare Diseases
1.4.5 Autoimmune Diseases
1.4.6 Pulmonary Diseases
1.4.7 Neurological Disorders
1.4.8 Others
1.5 Market by Application
1.5.1 Global Breakthrough Therapy (BT) Designation Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Breakthrough Therapy (BT) Designation Market Perspective (2015-2026)
2.2 Breakthrough Therapy (BT) Designation Growth Trends by Regions
2.2.1 Breakthrough Therapy (BT) Designation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Breakthrough Therapy (BT) Designation Historic Market Share by Regions (2015-2020)
2.2.3 Breakthrough Therapy (BT) Designation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Breakthrough Therapy (BT) Designation Market Growth Strategy
2.3.6 Primary Interviews with Key Breakthrough Therapy (BT) Designation Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Breakthrough Therapy (BT) Designation Players by Market Size
3.1.1 Global Top Breakthrough Therapy (BT) Designation Players by Revenue (2015-2020)
3.1.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Players (2015-2020)
3.1.3 Global Breakthrough Therapy (BT) Designation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breakthrough Therapy (BT) Designation Market Concentration Ratio
3.2.1 Global Breakthrough Therapy (BT) Designation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Breakthrough Therapy (BT) Designation Revenue in 2019
3.3 Breakthrough Therapy (BT) Designation Key Players Head office and Area Served
3.4 Key Players Breakthrough Therapy (BT) Designation Product Solution and Service
3.5 Date of Enter into Breakthrough Therapy (BT) Designation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Breakthrough Therapy (BT) Designation Historic Market Size by Type (2015-2020)
4.2 Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Type (2021-2026)
5 BREAKTHROUGH THERAPY (BT) DESIGNATION BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
5.2 Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Breakthrough Therapy (BT) Designation Market Size (2015-2020)
6.2 Breakthrough Therapy (BT) Designation Key Players in North America (2019-2020)
6.3 North America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
6.4 North America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Breakthrough Therapy (BT) Designation Market Size (2015-2020)
7.2 Breakthrough Therapy (BT) Designation Key Players in Europe (2019-2020)
7.3 Europe Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
7.4 Europe Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
8 CHINA
8.1 China Breakthrough Therapy (BT) Designation Market Size (2015-2020)
8.2 Breakthrough Therapy (BT) Designation Key Players in China (2019-2020)
8.3 China Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
8.4 China Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Breakthrough Therapy (BT) Designation Market Size (2015-2020)
9.2 Breakthrough Therapy (BT) Designation Key Players in Japan (2019-2020)
9.3 Japan Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
9.4 Japan Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Breakthrough Therapy (BT) Designation Market Size (2015-2020)
10.2 Breakthrough Therapy (BT) Designation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
10.4 Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
11 INDIA
11.1 India Breakthrough Therapy (BT) Designation Market Size (2015-2020)
11.2 Breakthrough Therapy (BT) Designation Key Players in India (2019-2020)
11.3 India Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
11.4 India Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Breakthrough Therapy (BT) Designation Market Size (2015-2020)
12.2 Breakthrough Therapy (BT) Designation Key Players in Central & South America (2019-2020)
12.3 Central & South America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
12.4 Central & South America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Breakthrough Therapy (BT) Designation Introduction
13.1.4 Roche Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Abbvie
13.2.1 Abbvie Company Details
13.2.2 Abbvie Business Overview and Its Total Revenue
13.2.3 Abbvie Breakthrough Therapy (BT) Designation Introduction
13.2.4 Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.2.5 Abbvie Recent Development
13.3 Novartis International AG
13.3.1 Novartis International AG Company Details
13.3.2 Novartis International AG Business Overview and Its Total Revenue
13.3.3 Novartis International AG Breakthrough Therapy (BT) Designation Introduction
13.3.4 Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.3.5 Novartis International AG Recent Development
13.4 Janssen
13.4.1 Janssen Company Details
13.4.2 Janssen Business Overview and Its Total Revenue
13.4.3 Janssen Breakthrough Therapy (BT) Designation Introduction
13.4.4 Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.4.5 Janssen Recent Development
13.5 BMS
13.5.1 BMS Company Details
13.5.2 BMS Business Overview and Its Total Revenue
13.5.3 BMS Breakthrough Therapy (BT) Designation Introduction
13.5.4 BMS Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.5.5 BMS Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview and Its Total Revenue
13.6.3 Eli Lilly Breakthrough Therapy (BT) Designation Introduction
13.6.4 Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Gilead
13.7.1 Gilead Company Details
13.7.2 Gilead Business Overview and Its Total Revenue
13.7.3 Gilead Breakthrough Therapy (BT) Designation Introduction
13.7.4 Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.7.5 Gilead Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Breakthrough Therapy (BT) Designation Introduction
13.8.4 Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Regeneron
13.9.1 Regeneron Company Details
13.9.2 Regeneron Business Overview and Its Total Revenue
13.9.3 Regeneron Breakthrough Therapy (BT) Designation Introduction
13.9.4 Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.9.5 Regeneron Recent Development
13.10 Acadia
13.10.1 Acadia Company Details
13.10.2 Acadia Business Overview and Its Total Revenue
13.10.3 Acadia Breakthrough Therapy (BT) Designation Introduction
13.10.4 Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.10.5 Acadia Recent Development
13.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Details
10.11.2 Boehringer Ingelheim Business Overview and Its Total Revenue
10.11.3 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Introduction
10.11.4 Boehringer Ingelheim Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.11.5 Boehringer Ingelheim Recent Development
13.12 Amgen
10.12.1 Amgen Company Details
10.12.2 Amgen Business Overview and Its Total Revenue
10.12.3 Amgen Breakthrough Therapy (BT) Designation Introduction
10.12.4 Amgen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.12.5 Amgen Recent Development
13.13 AstraZeneca
10.13.1 AstraZeneca Company Details
10.13.2 AstraZeneca Business Overview and Its Total Revenue
10.13.3 AstraZeneca Breakthrough Therapy (BT) Designation Introduction
10.13.4 AstraZeneca Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.13.5 AstraZeneca Recent Development
13.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview and Its Total Revenue
10.14.3 GlaxoSmithKline Breakthrough Therapy (BT) Designation Introduction
10.14.4 GlaxoSmithKline Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
13.15 Vertex
10.15.1 Vertex Company Details
10.15.2 Vertex Business Overview and Its Total Revenue
10.15.3 Vertex Breakthrough Therapy (BT) Designation Introduction
10.15.4 Vertex Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.15.5 Vertex Recent Development
13.16 Alexion
10.16.1 Alexion Company Details
10.16.2 Alexion Business Overview and Its Total Revenue
10.16.3 Alexion Breakthrough Therapy (BT) Designation Introduction
10.16.4 Alexion Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.16.5 Alexion Recent Development
13.17 Merck
10.17.1 Merck Company Details
10.17.2 Merck Business Overview and Its Total Revenue
10.17.3 Merck Breakthrough Therapy (BT) Designation Introduction
10.17.4 Merck Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.17.5 Merck Recent Development
13.18 Jazz Pharmaceuticals
10.18.1 Jazz Pharmaceuticals Company Details
10.18.2 Jazz Pharmaceuticals Business Overview and Its Total Revenue
10.18.3 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Introduction
10.18.4 Jazz Pharmaceuticals Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.18.5 Jazz Pharmaceuticals Recent Development
13.19 Exelixis
10.19.1 Exelixis Company Details
10.19.2 Exelixis Business Overview and Its Total Revenue
10.19.3 Exelixis Breakthrough Therapy (BT) Designation Introduction
10.19.4 Exelixis Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.19.5 Exelixis Recent Development
13.20 Eisai
10.20.1 Eisai Company Details
10.20.2 Eisai Business Overview and Its Total Revenue
10.20.3 Eisai Breakthrough Therapy (BT) Designation Introduction
10.20.4 Eisai Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.20.5 Eisai Recent Development
13.21 Takeda
10.21.1 Takeda Company Details
10.21.2 Takeda Business Overview and Its Total Revenue
10.21.3 Takeda Breakthrough Therapy (BT) Designation Introduction
10.21.4 Takeda Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.21.5 Takeda Recent Development
13.22 Pfizer
10.22.1 Pfizer Company Details
10.22.2 Pfizer Business Overview and Its Total Revenue
10.22.3 Pfizer Breakthrough Therapy (BT) Designation Introduction
10.22.4 Pfizer Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.22.5 Pfizer Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breakthrough Therapy (BT) Designation Revenue
1.4 Market Analysis by Type
1.4.1 Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 Infectious Diseases
1.4.4 Rare Diseases
1.4.5 Autoimmune Diseases
1.4.6 Pulmonary Diseases
1.4.7 Neurological Disorders
1.4.8 Others
1.5 Market by Application
1.5.1 Global Breakthrough Therapy (BT) Designation Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Breakthrough Therapy (BT) Designation Market Perspective (2015-2026)
2.2 Breakthrough Therapy (BT) Designation Growth Trends by Regions
2.2.1 Breakthrough Therapy (BT) Designation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Breakthrough Therapy (BT) Designation Historic Market Share by Regions (2015-2020)
2.2.3 Breakthrough Therapy (BT) Designation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Breakthrough Therapy (BT) Designation Market Growth Strategy
2.3.6 Primary Interviews with Key Breakthrough Therapy (BT) Designation Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Breakthrough Therapy (BT) Designation Players by Market Size
3.1.1 Global Top Breakthrough Therapy (BT) Designation Players by Revenue (2015-2020)
3.1.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Players (2015-2020)
3.1.3 Global Breakthrough Therapy (BT) Designation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breakthrough Therapy (BT) Designation Market Concentration Ratio
3.2.1 Global Breakthrough Therapy (BT) Designation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Breakthrough Therapy (BT) Designation Revenue in 2019
3.3 Breakthrough Therapy (BT) Designation Key Players Head office and Area Served
3.4 Key Players Breakthrough Therapy (BT) Designation Product Solution and Service
3.5 Date of Enter into Breakthrough Therapy (BT) Designation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Breakthrough Therapy (BT) Designation Historic Market Size by Type (2015-2020)
4.2 Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Type (2021-2026)
5 BREAKTHROUGH THERAPY (BT) DESIGNATION BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
5.2 Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Breakthrough Therapy (BT) Designation Market Size (2015-2020)
6.2 Breakthrough Therapy (BT) Designation Key Players in North America (2019-2020)
6.3 North America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
6.4 North America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Breakthrough Therapy (BT) Designation Market Size (2015-2020)
7.2 Breakthrough Therapy (BT) Designation Key Players in Europe (2019-2020)
7.3 Europe Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
7.4 Europe Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
8 CHINA
8.1 China Breakthrough Therapy (BT) Designation Market Size (2015-2020)
8.2 Breakthrough Therapy (BT) Designation Key Players in China (2019-2020)
8.3 China Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
8.4 China Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Breakthrough Therapy (BT) Designation Market Size (2015-2020)
9.2 Breakthrough Therapy (BT) Designation Key Players in Japan (2019-2020)
9.3 Japan Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
9.4 Japan Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Breakthrough Therapy (BT) Designation Market Size (2015-2020)
10.2 Breakthrough Therapy (BT) Designation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
10.4 Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
11 INDIA
11.1 India Breakthrough Therapy (BT) Designation Market Size (2015-2020)
11.2 Breakthrough Therapy (BT) Designation Key Players in India (2019-2020)
11.3 India Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
11.4 India Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Breakthrough Therapy (BT) Designation Market Size (2015-2020)
12.2 Breakthrough Therapy (BT) Designation Key Players in Central & South America (2019-2020)
12.3 Central & South America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
12.4 Central & South America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Breakthrough Therapy (BT) Designation Introduction
13.1.4 Roche Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Abbvie
13.2.1 Abbvie Company Details
13.2.2 Abbvie Business Overview and Its Total Revenue
13.2.3 Abbvie Breakthrough Therapy (BT) Designation Introduction
13.2.4 Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.2.5 Abbvie Recent Development
13.3 Novartis International AG
13.3.1 Novartis International AG Company Details
13.3.2 Novartis International AG Business Overview and Its Total Revenue
13.3.3 Novartis International AG Breakthrough Therapy (BT) Designation Introduction
13.3.4 Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.3.5 Novartis International AG Recent Development
13.4 Janssen
13.4.1 Janssen Company Details
13.4.2 Janssen Business Overview and Its Total Revenue
13.4.3 Janssen Breakthrough Therapy (BT) Designation Introduction
13.4.4 Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.4.5 Janssen Recent Development
13.5 BMS
13.5.1 BMS Company Details
13.5.2 BMS Business Overview and Its Total Revenue
13.5.3 BMS Breakthrough Therapy (BT) Designation Introduction
13.5.4 BMS Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.5.5 BMS Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview and Its Total Revenue
13.6.3 Eli Lilly Breakthrough Therapy (BT) Designation Introduction
13.6.4 Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Gilead
13.7.1 Gilead Company Details
13.7.2 Gilead Business Overview and Its Total Revenue
13.7.3 Gilead Breakthrough Therapy (BT) Designation Introduction
13.7.4 Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.7.5 Gilead Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Breakthrough Therapy (BT) Designation Introduction
13.8.4 Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Regeneron
13.9.1 Regeneron Company Details
13.9.2 Regeneron Business Overview and Its Total Revenue
13.9.3 Regeneron Breakthrough Therapy (BT) Designation Introduction
13.9.4 Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.9.5 Regeneron Recent Development
13.10 Acadia
13.10.1 Acadia Company Details
13.10.2 Acadia Business Overview and Its Total Revenue
13.10.3 Acadia Breakthrough Therapy (BT) Designation Introduction
13.10.4 Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
13.10.5 Acadia Recent Development
13.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Details
10.11.2 Boehringer Ingelheim Business Overview and Its Total Revenue
10.11.3 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Introduction
10.11.4 Boehringer Ingelheim Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.11.5 Boehringer Ingelheim Recent Development
13.12 Amgen
10.12.1 Amgen Company Details
10.12.2 Amgen Business Overview and Its Total Revenue
10.12.3 Amgen Breakthrough Therapy (BT) Designation Introduction
10.12.4 Amgen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.12.5 Amgen Recent Development
13.13 AstraZeneca
10.13.1 AstraZeneca Company Details
10.13.2 AstraZeneca Business Overview and Its Total Revenue
10.13.3 AstraZeneca Breakthrough Therapy (BT) Designation Introduction
10.13.4 AstraZeneca Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.13.5 AstraZeneca Recent Development
13.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview and Its Total Revenue
10.14.3 GlaxoSmithKline Breakthrough Therapy (BT) Designation Introduction
10.14.4 GlaxoSmithKline Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
13.15 Vertex
10.15.1 Vertex Company Details
10.15.2 Vertex Business Overview and Its Total Revenue
10.15.3 Vertex Breakthrough Therapy (BT) Designation Introduction
10.15.4 Vertex Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.15.5 Vertex Recent Development
13.16 Alexion
10.16.1 Alexion Company Details
10.16.2 Alexion Business Overview and Its Total Revenue
10.16.3 Alexion Breakthrough Therapy (BT) Designation Introduction
10.16.4 Alexion Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.16.5 Alexion Recent Development
13.17 Merck
10.17.1 Merck Company Details
10.17.2 Merck Business Overview and Its Total Revenue
10.17.3 Merck Breakthrough Therapy (BT) Designation Introduction
10.17.4 Merck Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.17.5 Merck Recent Development
13.18 Jazz Pharmaceuticals
10.18.1 Jazz Pharmaceuticals Company Details
10.18.2 Jazz Pharmaceuticals Business Overview and Its Total Revenue
10.18.3 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Introduction
10.18.4 Jazz Pharmaceuticals Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.18.5 Jazz Pharmaceuticals Recent Development
13.19 Exelixis
10.19.1 Exelixis Company Details
10.19.2 Exelixis Business Overview and Its Total Revenue
10.19.3 Exelixis Breakthrough Therapy (BT) Designation Introduction
10.19.4 Exelixis Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.19.5 Exelixis Recent Development
13.20 Eisai
10.20.1 Eisai Company Details
10.20.2 Eisai Business Overview and Its Total Revenue
10.20.3 Eisai Breakthrough Therapy (BT) Designation Introduction
10.20.4 Eisai Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.20.5 Eisai Recent Development
13.21 Takeda
10.21.1 Takeda Company Details
10.21.2 Takeda Business Overview and Its Total Revenue
10.21.3 Takeda Breakthrough Therapy (BT) Designation Introduction
10.21.4 Takeda Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.21.5 Takeda Recent Development
13.22 Pfizer
10.22.1 Pfizer Company Details
10.22.2 Pfizer Business Overview and Its Total Revenue
10.22.3 Pfizer Breakthrough Therapy (BT) Designation Introduction
10.22.4 Pfizer Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
10.22.5 Pfizer Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Breakthrough Therapy (BT) Designation Key Market Segments
Table 2. Key Players Covered: Ranking by Breakthrough Therapy (BT) Designation Revenue
Table 3. Ranking of Global Top Breakthrough Therapy (BT) Designation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncology
Table 6. Key Players of Infectious Diseases
Table 7. Key Players of Rare Diseases
Table 8. Key Players of Autoimmune Diseases
Table 9. Key Players of Pulmonary Diseases
Table 10. Key Players of Neurological Disorders
Table 11. Key Players of Others
Table 12. Global Breakthrough Therapy (BT) Designation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Breakthrough Therapy (BT) Designation Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Breakthrough Therapy (BT) Designation Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Breakthrough Therapy (BT) Designation Market Share by Regions (2015-2020)
Table 16. Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Breakthrough Therapy (BT) Designation Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Breakthrough Therapy (BT) Designation Market Growth Strategy
Table 22. Main Points Interviewed from Key Breakthrough Therapy (BT) Designation Players
Table 23. Global Breakthrough Therapy (BT) Designation Revenue by Players (2015-2020) (Million US$)
Table 24. Global Breakthrough Therapy (BT) Designation Market Share by Players (2015-2020)
Table 25. Global Top Breakthrough Therapy (BT) Designation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2019)
Table 26. Global Breakthrough Therapy (BT) Designation by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Breakthrough Therapy (BT) Designation Product Solution and Service
Table 29. Date of Enter into Breakthrough Therapy (BT) Designation Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 32. Global Breakthrough Therapy (BT) Designation Market Size Share by Type (2015-2020)
Table 33. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type (2021-2026)
Table 34. Global Breakthrough Therapy (BT) Designation Market Size Share by Application (2015-2020)
Table 35. Global Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 36. Global Breakthrough Therapy (BT) Designation Market Size Share by Application (2021-2026)
Table 37. North America Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 39. North America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 40. North America Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 41. North America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 42. North America Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 43. Europe Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 45. Europe Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 47. Europe Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 49. China Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 50. China Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 51. China Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 52. China Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 53. China Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 54. China Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 55. Japan Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 57. Japan Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 59. Japan Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 63. Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 65. Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 67. India Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 68. India Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 69. India Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 70. India Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 71. India Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 72. India Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 75. Central & South America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 77. Central & South America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Abbvie Company Details
Table 85. Abbvie Business Overview
Table 86. Abbvie Product
Table 87. Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 88. Abbvie Recent Development
Table 89. Novartis International AG Company Details
Table 90. Novartis International AG Business Overview
Table 91. Novartis International AG Product
Table 92. Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 93. Novartis International AG Recent Development
Table 94. Janssen Company Details
Table 95. Janssen Business Overview
Table 96. Janssen Product
Table 97. Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 98. Janssen Recent Development
Table 99. BMS Company Details
Table 100. BMS Business Overview
Table 101. BMS Product
Table 102. BMS Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 103. BMS Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Product
Table 107. Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 108. Eli Lilly Recent Development
Table 109. Gilead Company Details
Table 110. Gilead Business Overview
Table 111. Gilead Product
Table 112. Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 113. Gilead Recent Development
Table 114. Sanofi Business Overview
Table 115. Sanofi Product
Table 116. Sanofi Company Details
Table 117. Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 118. Sanofi Recent Development
Table 119. Regeneron Company Details
Table 120. Regeneron Business Overview
Table 121. Regeneron Product
Table 122. Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 123. Regeneron Recent Development
Table 124. Acadia Company Details
Table 125. Acadia Business Overview
Table 126. Acadia Product
Table 127. Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 128. Acadia Recent Development
Table 129. Boehringer Ingelheim Company Details
Table 130. Boehringer Ingelheim Business Overview
Table 131. Boehringer Ingelheim Product
Table 132. Boehringer Ingelheim Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 133. Boehringer Ingelheim Recent Development
Table 134. Amgen Company Details
Table 135. Amgen Business Overview
Table 136. Amgen Product
Table 137. Amgen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 138. Amgen Recent Development
Table 139. AstraZeneca Company Details
Table 140. AstraZeneca Business Overview
Table 141. AstraZeneca Product
Table 142. AstraZeneca Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 143. AstraZeneca Recent Development
Table 144. GlaxoSmithKline Company Details
Table 145. GlaxoSmithKline Business Overview
Table 146. GlaxoSmithKline Product
Table 147. GlaxoSmithKline Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 148. GlaxoSmithKline Recent Development
Table 149. Vertex Company Details
Table 150. Vertex Business Overview
Table 151. Vertex Product
Table 152. Vertex Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 153. Vertex Recent Development
Table 154. Alexion Company Details
Table 155. Alexion Business Overview
Table 156. Alexion Product
Table 157. Alexion Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 158. Alexion Recent Development
Table 159. Merck Company Details
Table 160. Merck Business Overview
Table 161. Merck Product
Table 162. Merck Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 163. Merck Recent Development
Table 164. Jazz Pharmaceuticals Company Details
Table 165. Jazz Pharmaceuticals Business Overview
Table 166. Jazz Pharmaceuticals Product
Table 167. Jazz Pharmaceuticals Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 168. Jazz Pharmaceuticals Recent Development
Table 169. Exelixis Company Details
Table 170. Exelixis Business Overview
Table 171. Exelixis Product
Table 172. Exelixis Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 173. Exelixis Recent Development
Table 174. Eisai Company Details
Table 175. Eisai Business Overview
Table 176. Eisai Product
Table 177. Eisai Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 178. Eisai Recent Development
Table 179. Takeda Company Details
Table 180. Takeda Business Overview
Table 181. Takeda Product
Table 182. Takeda Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 183. Takeda Recent Development
Table 184. Pfizer Company Details
Table 185. Pfizer Business Overview
Table 186. Pfizer Product
Table 187. Pfizer Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 188. Pfizer Recent Development
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
Table 1. Breakthrough Therapy (BT) Designation Key Market Segments
Table 2. Key Players Covered: Ranking by Breakthrough Therapy (BT) Designation Revenue
Table 3. Ranking of Global Top Breakthrough Therapy (BT) Designation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncology
Table 6. Key Players of Infectious Diseases
Table 7. Key Players of Rare Diseases
Table 8. Key Players of Autoimmune Diseases
Table 9. Key Players of Pulmonary Diseases
Table 10. Key Players of Neurological Disorders
Table 11. Key Players of Others
Table 12. Global Breakthrough Therapy (BT) Designation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Breakthrough Therapy (BT) Designation Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Breakthrough Therapy (BT) Designation Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Breakthrough Therapy (BT) Designation Market Share by Regions (2015-2020)
Table 16. Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Breakthrough Therapy (BT) Designation Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Breakthrough Therapy (BT) Designation Market Growth Strategy
Table 22. Main Points Interviewed from Key Breakthrough Therapy (BT) Designation Players
Table 23. Global Breakthrough Therapy (BT) Designation Revenue by Players (2015-2020) (Million US$)
Table 24. Global Breakthrough Therapy (BT) Designation Market Share by Players (2015-2020)
Table 25. Global Top Breakthrough Therapy (BT) Designation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2019)
Table 26. Global Breakthrough Therapy (BT) Designation by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Breakthrough Therapy (BT) Designation Product Solution and Service
Table 29. Date of Enter into Breakthrough Therapy (BT) Designation Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 32. Global Breakthrough Therapy (BT) Designation Market Size Share by Type (2015-2020)
Table 33. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type (2021-2026)
Table 34. Global Breakthrough Therapy (BT) Designation Market Size Share by Application (2015-2020)
Table 35. Global Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 36. Global Breakthrough Therapy (BT) Designation Market Size Share by Application (2021-2026)
Table 37. North America Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 39. North America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 40. North America Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 41. North America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 42. North America Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 43. Europe Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 45. Europe Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 47. Europe Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 49. China Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 50. China Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 51. China Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 52. China Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 53. China Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 54. China Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 55. Japan Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 57. Japan Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 59. Japan Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 63. Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 65. Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 67. India Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 68. India Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 69. India Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 70. India Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 71. India Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 72. India Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Breakthrough Therapy (BT) Designation Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Breakthrough Therapy (BT) Designation Market Share (2019-2020)
Table 75. Central & South America Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Breakthrough Therapy (BT) Designation Market Share by Type (2015-2020)
Table 77. Central & South America Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Breakthrough Therapy (BT) Designation Market Share by Application (2015-2020)
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Abbvie Company Details
Table 85. Abbvie Business Overview
Table 86. Abbvie Product
Table 87. Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 88. Abbvie Recent Development
Table 89. Novartis International AG Company Details
Table 90. Novartis International AG Business Overview
Table 91. Novartis International AG Product
Table 92. Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 93. Novartis International AG Recent Development
Table 94. Janssen Company Details
Table 95. Janssen Business Overview
Table 96. Janssen Product
Table 97. Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 98. Janssen Recent Development
Table 99. BMS Company Details
Table 100. BMS Business Overview
Table 101. BMS Product
Table 102. BMS Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 103. BMS Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Product
Table 107. Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 108. Eli Lilly Recent Development
Table 109. Gilead Company Details
Table 110. Gilead Business Overview
Table 111. Gilead Product
Table 112. Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 113. Gilead Recent Development
Table 114. Sanofi Business Overview
Table 115. Sanofi Product
Table 116. Sanofi Company Details
Table 117. Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 118. Sanofi Recent Development
Table 119. Regeneron Company Details
Table 120. Regeneron Business Overview
Table 121. Regeneron Product
Table 122. Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 123. Regeneron Recent Development
Table 124. Acadia Company Details
Table 125. Acadia Business Overview
Table 126. Acadia Product
Table 127. Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 128. Acadia Recent Development
Table 129. Boehringer Ingelheim Company Details
Table 130. Boehringer Ingelheim Business Overview
Table 131. Boehringer Ingelheim Product
Table 132. Boehringer Ingelheim Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 133. Boehringer Ingelheim Recent Development
Table 134. Amgen Company Details
Table 135. Amgen Business Overview
Table 136. Amgen Product
Table 137. Amgen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 138. Amgen Recent Development
Table 139. AstraZeneca Company Details
Table 140. AstraZeneca Business Overview
Table 141. AstraZeneca Product
Table 142. AstraZeneca Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 143. AstraZeneca Recent Development
Table 144. GlaxoSmithKline Company Details
Table 145. GlaxoSmithKline Business Overview
Table 146. GlaxoSmithKline Product
Table 147. GlaxoSmithKline Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 148. GlaxoSmithKline Recent Development
Table 149. Vertex Company Details
Table 150. Vertex Business Overview
Table 151. Vertex Product
Table 152. Vertex Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 153. Vertex Recent Development
Table 154. Alexion Company Details
Table 155. Alexion Business Overview
Table 156. Alexion Product
Table 157. Alexion Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 158. Alexion Recent Development
Table 159. Merck Company Details
Table 160. Merck Business Overview
Table 161. Merck Product
Table 162. Merck Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 163. Merck Recent Development
Table 164. Jazz Pharmaceuticals Company Details
Table 165. Jazz Pharmaceuticals Business Overview
Table 166. Jazz Pharmaceuticals Product
Table 167. Jazz Pharmaceuticals Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 168. Jazz Pharmaceuticals Recent Development
Table 169. Exelixis Company Details
Table 170. Exelixis Business Overview
Table 171. Exelixis Product
Table 172. Exelixis Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 173. Exelixis Recent Development
Table 174. Eisai Company Details
Table 175. Eisai Business Overview
Table 176. Eisai Product
Table 177. Eisai Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 178. Eisai Recent Development
Table 179. Takeda Company Details
Table 180. Takeda Business Overview
Table 181. Takeda Product
Table 182. Takeda Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 183. Takeda Recent Development
Table 184. Pfizer Company Details
Table 185. Pfizer Business Overview
Table 186. Pfizer Product
Table 187. Pfizer Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020) (Million US$)
Table 188. Pfizer Recent Development
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Breakthrough Therapy (BT) Designation Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. Infectious Diseases Features
Figure 4. Rare Diseases Features
Figure 5. Autoimmune Diseases Features
Figure 6. Pulmonary Diseases Features
Figure 7. Neurological Disorders Features
Figure 8. Others Features
Figure 9. Global Breakthrough Therapy (BT) Designation Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Laboratories Case Studies
Figure 14. Breakthrough Therapy (BT) Designation Report Years Considered
Figure 15. Global Breakthrough Therapy (BT) Designation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Breakthrough Therapy (BT) Designation Market Share by Regions: 2020 VS 2026
Figure 17. Global Breakthrough Therapy (BT) Designation Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Breakthrough Therapy (BT) Designation Market Share by Players in 2019
Figure 20. Global Top Breakthrough Therapy (BT) Designation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Breakthrough Therapy (BT) Designation Revenue in 2019
Figure 22. North America Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 31. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Abbvie Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 33. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis International AG Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 35. Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Janssen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 37. BMS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. BMS Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 39. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Eli Lilly Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 41. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Gilead Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 43. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sanofi Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 45. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Regeneron Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 47. Acadia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Acadia Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 49. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 51. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Amgen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 53. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AstraZeneca Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 55. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. GlaxoSmithKline Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 57. Vertex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Vertex Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 59. Alexion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Alexion Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 61. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Merck Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 63. Jazz Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Jazz Pharmaceuticals Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 65. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Exelixis Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 67. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Eisai Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Figure 1. Global Breakthrough Therapy (BT) Designation Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. Infectious Diseases Features
Figure 4. Rare Diseases Features
Figure 5. Autoimmune Diseases Features
Figure 6. Pulmonary Diseases Features
Figure 7. Neurological Disorders Features
Figure 8. Others Features
Figure 9. Global Breakthrough Therapy (BT) Designation Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Laboratories Case Studies
Figure 14. Breakthrough Therapy (BT) Designation Report Years Considered
Figure 15. Global Breakthrough Therapy (BT) Designation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Breakthrough Therapy (BT) Designation Market Share by Regions: 2020 VS 2026
Figure 17. Global Breakthrough Therapy (BT) Designation Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Breakthrough Therapy (BT) Designation Market Share by Players in 2019
Figure 20. Global Top Breakthrough Therapy (BT) Designation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Breakthrough Therapy (BT) Designation Revenue in 2019
Figure 22. North America Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Breakthrough Therapy (BT) Designation Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 31. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Abbvie Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 33. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis International AG Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 35. Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Janssen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 37. BMS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. BMS Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 39. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Eli Lilly Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 41. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Gilead Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 43. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sanofi Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 45. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Regeneron Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 47. Acadia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Acadia Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 49. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 51. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Amgen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 53. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AstraZeneca Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 55. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. GlaxoSmithKline Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 57. Vertex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Vertex Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 59. Alexion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Alexion Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 61. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Merck Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 63. Jazz Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Jazz Pharmaceuticals Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 65. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Exelixis Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 67. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Eisai Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2015-2020)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
